Summary
Health economics has benefitted from, and contributed towards, the field of health-related quality of life (HRQL). This chapter describes the framework of economic evaluation and shows where, and why, measures of HRQL are used. The main contribution of health economics has occurred in the area of valuation, and a range of valuation techniques is presented. Increased demand for economic evaluations by central level decision-makers all over the world has resulted in the development of league tables of cost-effectiveness and the raising of justifiable questions regarding international comparability of costs and HRQL.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aaronson N, Acquadro C, Alonso J, Apolone G, Bucquet D, Bullinger M, Bungay K, Fukuhara S, Gandek B, Keller S, Razavi D, Sanson-Fisher R, Sullivan M, Wood-Dauphinee S, Wagner A, Ware J (1992) International quality of life assessment (lQOLA) project. Quality Life Res 1: 349–351
Ahmed W, Kernohan E, Baker M (1989) Cross-cultural use of socio-medical indicators in British Asians. Health Pol 13: 95–102
Alban A (1987) Economic appraisal: what is the use revisited. Paper presented at the Eighth Nordic Health Economists’ Study Group
Alonso J, Anto JM, Moreno C (1990) Spanish version of the Nottingham Health Profile: translation and preliminary validity Am J Public Health 80: 6: 704–708
Backhouse M, Backhouse R, Edey S (1992) Economic evaluation bibliography. Health Econ 1 (suppl): 1–236
Bergner M, Bobbitt RA, Carter WB, Gilson BS (1981) The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 19: 785–805
Berman P (1982) Selective primary health care: Is efficient sufficient? Social Sci Med 16: 1056
Birch S, Gafni A (1992) Cost-Effectiveness/Utility Analyses: Do current decision rules lead us to where we want to be? J Health Econ 11: 279–296
Bombardier C, Ware J, Russel IJ, Laison M, Chalmers A, Leighton-Read (1986) Auranofin in therapy and quality of life of patients with rheumatoid arthritis. Am J Med 81: 565–578
Brazier J, Harper R, Jones N, Cathain A, Usherwood T, Westlake L (1992) Validation of the SF-36 Health Survey Questionnaire: New outcome measure for primary care. Brit Med J 305: 6346, 160–164
Buxton M (1992) Uncertainties with QALYs and possible improvements. In: HopkinsA (ed) Different measures of the quality of life and the uses to which they may be put. Royal College of Physicians London, UK
Buxton M, Ashby J (1988) The Time Trade-Off approach to health state valuation. In: Teeling-Smith G (ed) Measuring health: A practical approach. John Wiley, Chichester
Chambers LW, MacDonald LA, Thgwell P, Buchanan W, Kraag G (1982) The McMaster Health Index Questionnaire as a measure of quality of life for patients with rheumatoid arthritis. J Rheumatol 9: 780–784
Commonwealth of Australia (1990) Guidelines for preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including submissions involving economic analyses. Woden (ACT) Department of Health, Housing and Community Services
Croog SH, Levine S, Testa M, Brown B, Bulpitt C, Jenkins D, Klerman G, Williams G (1986) The effect of anti-hypertensive therapy on the quality of life. New Engl Med J 26: 1657–1665
Culyer A, Wagstaff A (1992) QALYs versus HYEs: a theoretical exposition. Centre for Health Economics Discussion Paper No. 99. University of York, UK
Davies L, Coyle D, Drummond M (1993) Current status of economic appraisal of health technology in the European Community: Report of the network. Paper presented to International Society of Technology Assessment in Health Care, Sorrento
Drummond M (1992) Cost-effectiveness guidelines for reimbursement of pharmaceuticals: Is economic evaluation ready for its enhanced status? -Health Econ 1: 85–92
Drummond M, Stoddart G, Torrance G (1987) Methods for the economic evaluation of health care programmes. Oxford Medical Publications, Oxford University Press
Drummond M, Torrance G, Mason J (1993) Cost-effectiveness league tables: more harm than good? Social Sci Med 37: 1: 33–40
EuroQol Group (1990) EuroQol: A new facility for the measurement of health related quality of life. Health Pol 16: 199–208
Feeny D, Torrance GW (1988) Incorporating utility based quality of life assessment measures in clinical trials: Two examples. McMaster University Working Papers
Fox-Rushby J (1993) The measurement and valuation of health related quality of life: The case of differing pacing modalities. Doctoral Thesis, Brunei University
Froberg D, Kane K (1989) Methodology for health state preferences: Part 4. J Clin Epidemiol 22: 675–685
Gerard K (1992) Cost Utility Analysis: A policy makers guide to the state of the art. Health Pol 21: 3: 249–280
Gerard K, Mooney G (1993) QALY league tables: handle with care. Health Econ 2: 59–64
Gudex C, Kind P, van Dalen H, Durand M, Morris J, Williams A (1993) Comparing scaling methods for health state valuations - Rosser revisited. Centre for Health Economics Discussion Paper No 107, York University
Guyatt G, Walter S, Norman G (1987) Measuring Change over time: assessing the usefulness of evaluative instruments. J Chronic Diseases 38: 517–524
Guyatt G, van Zanten S, Feeny D, Patrick D (1989) Measuring quality of life in clinical trials. J Chronic Diseases 40: 171–178
Health Services Commission (1991) The Prioritised Health Services List. Salern: HSC, USA
Hendricson W, Russell I, Prihoda T, Jacobson J, Rogan A, Bishop G (1989) An Approach to developing a valid Spanish language translation of a health-status questionnaire. Med Care 27: 10: 959–966
Hunt S (1986) Cross cultural issues in the use of socio-medical indicators. Health Pol 6: 149–158
Hunt SM, McEwen S, McKenna SP (1986) Measuring Health Status. Croom Helm, London
Hunt S, Alonso J, Bucquet D, Niero M, Wiklund I, McKenna S (1991) Cross-cultural adaptation of health measures. Health Pol 19: 33–44
Jamison D, Mosley W, Measham A, Bobadilla J (eds) (1993) Disease control priorities in developing countries. Oxford Medical Publications, Oxford
Laidler D (1981) Introduction to microeconomics. Philip Allan Publishers, Oxford
Loomes G, McKenzie L (1989) The use of QALYs in health care decision making. Social Sci Med 28: 4: 299–308
Mehrez A, Gafni A (1989) Quality Adjusted Life Years, utility theory and health-years equivalents. Med Decision Making 9: 142–149
Mishan EJ (1971) Cost-Benefit Analysis. Unwin University Books, UK
Mulley AG (1989) Assessing patient’s utilities: Can the end justify the means? Med Care 27: 5269–5281
Nord E (1992) An alternative to QALYs: The saved young life equivalent (SAVE). Brit Med J 305: 875–877
Ontario Ministry of Health (1991) Guidelines for preparation of economic analysis to be included in submission to Drug Programs Branch for listing in the Ontario Drug Benefit Formulary/Comparative Drug Index. Toronto, Ministry of Health
Orley J (1992) News from the World Health Organisation. Quality Life Res 1: 277
Patrick D, Deyo R (1989) Generic and disease specific measures in assessing health status and quality of life. Med Care 27 (suppl): 5217–5232
Robinson R (1993) Cost-Benefit Analysis. Brit Med J 307: 924–926
Rosser R, Kind P (1978) A scale of valuations of states of illness. Is there a social consensus? Int J Epidemiol 7: 347–358
Tan-Torres T (1990) Comparison of different methods of eliciting utilities for outcome states in leprosy. Report to TDR/WHO
Torrance GW (1986) Measurement of health state utilities for economic appraisal. J Health Econ 5: 1–30
Torrance GW, Thomas WH, Sackett D (1972) A utility maximisation model for evaluation of health care programmes. Health Services Res 7: 118–133
Ware J, Sherbourne CD (1992) The MOS 36 item short form health survey. Med Care 30: 473–483
Williams A (1984) Economics of coronary artery by-pass grafting. Brit Med J 291: 326–329
Williams J, Wood-Dauphinee S (1989) Assessing quality of life: measures of utility. In: Quality of life and technology assessment. Monograph of the Council on Health Care Technology, National Academy Press, Washington DC
World Bank (1993) Investing in Health. World Development Report 1993. Oxford University Press
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Fox-Rushby, J.A. (1994). The Relationship Between Health Economics and Health-Related Quality of Life. In: Orley, J., Kuyken, W. (eds) Quality of Life Assessment: International Perspectives. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79123-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-79123-9_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79125-3
Online ISBN: 978-3-642-79123-9
eBook Packages: Springer Book Archive